212,066 Shares in Oscar Health, Inc. $OSCR Acquired by Halter Ferguson Financial Inc.

Key Points

• Halter Ferguson Financial Inc. has purchased a new stake in Oscar Health, acquiring 212,066 shares valued at approximately $4.5 million, making it the 8th largest holding in the firm.
• Oscar Health reported a revenue increase of 29% year-over-year but posted a loss of $0.89 earnings per share, beating analyst expectations by $0.01.
• Several analysts have downgraded Oscar Health's stock ratings, with a consensus rating of "Strong Sell" and a price target of $12.07, reflecting negative market outlook.

Halter Ferguson Financial Inc. purchased a new position in Oscar Health, Inc. (NYSE:OSCR - Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 212,066 shares of the company's stock, valued at approximately $4,547,000. Oscar Health makes up about 1.6% of Halter Ferguson Financial Inc.'s portfolio, making the stock its 8th biggest holding. Halter Ferguson Financial Inc. owned approximately 0.08% of Oscar Health at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in OSCR. BNP Paribas Financial Markets purchased a new stake in Oscar Health in the 4th quarter worth $590,000. Cetera Investment Advisers boosted its stake in Oscar Health by 17.1% during the 4th quarter. Cetera Investment Advisers now owns 27,066 shares of the company's stock worth $364,000 after purchasing an additional 3,961 shares during the last quarter. ProShare Advisors LLC boosted its stake in Oscar Health by 52.7% during the 4th quarter. ProShare Advisors LLC now owns 56,098 shares of the company's stock worth $754,000 after purchasing an additional 19,356 shares during the last quarter. Toronto Dominion Bank acquired a new stake in Oscar Health during the 4th quarter worth $1,008,000. Finally, Thrive Capital Management LLC boosted its stake in Oscar Health by 33.4% during the 4th quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company's stock worth $85,258,000 after purchasing an additional 1,588,395 shares during the last quarter. Hedge funds and other institutional investors own 75.70% of the company's stock.

Oscar Health Trading Down 2.3%

NYSE:OSCR traded down $0.42 on Tuesday, reaching $18.08. 13,906,678 shares of the company's stock were exchanged, compared to its average volume of 13,987,063. The company has a quick ratio of 0.86, a current ratio of 0.86 and a debt-to-equity ratio of 0.26. The firm has a market capitalization of $4.68 billion, a price-to-earnings ratio of -22.36 and a beta of 1.87. The business has a fifty day moving average of $16.26 and a 200-day moving average of $15.28. Oscar Health, Inc. has a 52-week low of $11.20 and a 52-week high of $22.78.

Oscar Health (NYSE:OSCR - Get Free Report) last issued its quarterly earnings results on Wednesday, August 6th. The company reported ($0.89) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.90) by $0.01. The company had revenue of $2.86 billion for the quarter, compared to analyst estimates of $2.88 billion. Oscar Health had a negative net margin of 1.50% and a negative return on equity of 13.78%. The business's revenue for the quarter was up 29.0% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.20 earnings per share. As a group, analysts expect that Oscar Health, Inc. will post 0.69 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several brokerages have issued reports on OSCR. Robert W. Baird reaffirmed a "neutral" rating and set a $14.00 target price (down previously from $28.00) on shares of Oscar Health in a research note on Friday, July 25th. Piper Sandler lowered their target price on shares of Oscar Health from $14.00 to $13.00 and set a "neutral" rating on the stock in a research note on Thursday, August 14th. Baird R W cut shares of Oscar Health from a "strong-buy" rating to a "hold" rating in a research note on Friday, July 25th. Barclays lowered their price target on shares of Oscar Health from $17.00 to $11.00 and set an "underweight" rating on the stock in a research report on Wednesday, July 23rd. Finally, UBS Group reissued a "sell" rating and set a $11.00 price target (down previously from $15.00) on shares of Oscar Health in a research report on Tuesday, July 15th. Four investment analysts have rated the stock with a Hold rating and five have issued a Sell rating to the company. According to MarketBeat, the company has a consensus rating of "Strong Sell" and a consensus target price of $12.07.

Oscar Health Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.